Losses to follow-up of HIV-infected people in the Spanish VACH cohort over the period between 2013 and 2014: The importance of sociodemographic factors
Ramón Teira(Hospital Sierrallana), Pepa Muñoz-Sánchez(Hospital de Basurto), Marta Montero, Elisa Martínez(University Hospital and Clinics), Elisabeth Deig(Hospital General de Granollers), Francisco Téllez(Hospital Universitario Puerto Real), Francisco González(Universidad de Huelva), Joaquim Peraire(Instituto de Salud Carlos III), Núria Espinosa, Marı́a José Galindo(Hospital Clínico Universitario de Valencia), Fernando Lozano de León(Hospital Universitario de Valme)
Enfermedades infecciosas y microbiologia clinica (English ed )
March 23, 2019
Cited by 3
Related Papers
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
|The Lancet Infectious Diseases|2015|143
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
|The Lancet HIV|2021|110